Payment Suspensions and Asset Freezes in Compounding Pharmacy Cases

A compounding pharmacy can lose access to its own money before a single charge is filed. Medicare and Medicaid can suspend payments on a credible allegation of fraud alone, a federal court can freeze operating accounts under the federal health care fraud injunction statute, and the FDA can seize compounded drug inventory through a seizure warrant. None of the three requires a conviction, an indictment, or a completed investigation. Each can take effect while the government is still deciding whether to charge anyone at all.

Medicare and Medicaid Payment Suspensions

Under 42 CFR 405.371, a Medicare contractor may suspend payments on a credible allegation of fraud alone, after consulting HHS-OIG, and the Department of Justice where appropriate, unless good cause says otherwise. The suspension can run up to 18 months, reevaluated every 180 days, and DOJ can ask in writing for a longer hold tied to a pending case. 42 CFR 455.23 governs the Medicaid version: a state agency can suspend payments on the same standard before giving the provider notice at all. Written notice has to follow within five days, or up to 90 days if law enforcement asks for the delay. Both rules let the suspension take effect first and the explanation follow.

Civil Injunctions and Asset Freezes Under Federal Fraud Law

18 U.S.C. 1345 lets the Attorney General seek a civil injunction tied to a federal health care offense, reaching conduct still underway: a person "committing or about to commit" a federal health care offense is enough. The court can issue a restraining order blocking a pharmacy or its owners from transferring property traceable to the alleged fraud, and can appoint a receiver over the frozen assets. No bond is required, and no criminal charge or conviction has to come first. A freeze under Section 1345 can land alongside a grand jury subpoena, a civil investigative demand tied to a False Claims Act inquiry, or an anti-kickback statute referral, since the kickback exposure behind a freeze can trace to the marketing arrangements covered in Compounding Pharmacy Telehealth Marketing and Kickback Risk.

FDA Seizure Warrants and Injunctions

The FDA does not need a payment suspension or a court freeze to take compounded drugs off the shelf. 21 U.S.C. 334 lets the government seize adulterated or misbranded drugs directly, against the product itself rather than the pharmacy. 21 U.S.C. 332 covers the other path: a court order enjoining ongoing FDCA violations. A pharmacy can intervene as a claimant once a seizure is filed, ask for the case to be heard near its principal place of business, and can get the product released on a bond while the case proceeds. A seizure or injunction can follow the records request described in FDA Inspection of a Compounding Pharmacy: Scope, Records and Refusals.

A credible allegation of fraud, not a conviction, is enough to suspend a compounding pharmacy's Medicare and Medicaid payments while the government investigates.

Contesting a Suspension or Freeze Before It Becomes Permanent

Each mechanism opens a different angle for counsel, and compounding pharmacy defense turns on which lever is in play and how early counsel gets involved. A Medicare or Medicaid suspension can be challenged on the good cause exceptions, including that the pharmacy is a sole source of care in its area or that a lesser remedy protects program funds just as well. A Section 1345 freeze can be narrowed by showing which specific assets trace to the alleged conduct, since the statute reaches property connected to the violation, not every account the pharmacy owns. A seizure can be met with a claim and a bond request to get inventory back into commerce while litigated. Waiting to see whether charges follow gives up the window when these arguments work best.

Why Early Legal Counsel Is Critical

It is critical that compounding pharmacies promptly retain experienced healthcare defense counsel upon receiving a payment suspension notice, a seizure warrant, a restraining order, or any other government inquiry. Early legal intervention can protect the pharmacy's rights, shape appropriate responses to government requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators directly. Delaying representation can significantly affect the outcome of a matter and expose the pharmacy to unnecessary risk.

How Health Law Alliance Can Help

Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience. A pharmacy weighing a purchase should also run the due diligence covered in Buying a Compounding Pharmacy: FDA and Board Due Diligence. If your pharmacy's payments have been suspended or its assets frozen, contact us for a free, confidential consultation through our criminal healthcare fraud defense page.